š Guideline basis
ASE/EACVI 2015 chamber quantification (Lang et al., JASE 2015;28:1ā39); ASE 2019 comprehensive TTE examination; ESICM PRICES consensus on CCE reporting (Intensive Care Med 2021); EACVI/ASE strain standardisation task force.
Pathophysiology & Mechanisms
Ejection fraction is not contractility. It is the ratio of stroke volume to end-diastolic volume, and therefore a composite of preload, afterload, heart rate, synchrony, and intrinsic inotropic state. Three consequences dominate ICU interpretation:
- Afterload dependence. In vasoplegic shock, systemic vascular resistance falls, ejection becomes easy, and EF rises even when intrinsic contractility is depressed. Restoring perfusion pressure with noradrenaline then "unmasks" a low EF that was present all along. The EF changed; the myocardium did not.
- Preload dependence. A hypovolaemic ventricle with a small end-diastolic volume ejects a small absolute stroke volume at a high fractional shortening ā the "hyperdynamic, kissing" ventricle. EF is 75%; cardiac output is 2.4 L/min.
- Geometric assumption dependence. Every volumetric method assumes a shape. Regional wall motion abnormalities, aneurysm, or a foreshortened image break the assumption.
The mechanical substrate: subendocardial longitudinal fibres shorten first and are the most vulnerable to ischaemia, elevated wall stress, and inflammatory injury. Circumferential mid-wall fibres, which contribute most to ejection fraction, are relatively preserved until later. This anatomy is why longitudinal function (GLS, MAPSE, sā²) falls before EF falls ā the earliest detectable systolic abnormality in sepsis, in cardiotoxicity, and in infiltrative disease is longitudinal, and EF is normal at that point.
Clinical Phenotypes
Phenotype | EF | SV / CO | LV size | Typical setting |
Hyperdynamic, underfilled | >70% | Low | Small, end-systolic cavity obliteration | Hypovolaemia, haemorrhage, early distributive shock |
Hyperdynamic, high-output | >65% | High | Normal or small | Sepsis with vasoplegia, thyrotoxicosis, liver failure, severe anaemia |
Depressed, acute, non-dilated | 20ā45% | Low | Normal cavity size | Sepsis-induced cardiomyopathy, stress cardiomyopathy, myocarditis |
Depressed, chronic, dilated | <35% | Low | Dilated, spherical, with secondary MR | Chronic dilated cardiomyopathy decompensated by the acute illness |
Regional | Variable | Variable | Segmental | Acute coronary syndrome, stress cardiomyopathy (apical ballooning) |
Normal EF, abnormal longitudinal | >55% | Variable | Normal | Early septic cardiomyopathy, amyloid, HFpEF |
Quantification methods
Biplane method of discs (Simpson's)
The reference echocardiographic method. Trace the endocardial border at end-diastole and end-systole in A4C and A2C; the software sums stacked elliptical discs.
EF = ((EDV - ESV) / EDV) Ć 100Requirements: unforeshortened apical views; endocardium visualised in ā„80% of the border (otherwise use an ultrasound enhancing agent); papillary muscles and trabeculae included in the cavity, not the wall; end-diastole and end-systole defined by ECG and valve motion.
Normal LVEF (ASE/EACVI 2015): 52ā72% in men, 54ā74% in women. Values below these define abnormal; severe dysfunction is conventionally <30%.
Visual (eyeball) estimation
Validated against volumetric methods when performed by trained operators, and the practical default in the ICU. Its accuracy is category-level, not point-level: reporting "moderately impaired" is defensible; reporting "EF 42%" from visual estimation is not. Categories: hyperdynamic (>70%), normal (52ā72%), mildly reduced (41ā51%), moderately reduced (30ā40%), severely reduced (<30%).
Fractional shortening and Teichholz
FS = ((LVIDd - LVIDs) / LVIDd) Ć 100Normal FS ā 25ā45%. Do not use the Teichholz or Quinones formulas to derive EF from linear dimensions in the ICU: they cube a single basal measurement, and in the presence of regional dysfunction, septal flattening from RV overload, or post-cardiotomy septal motion, the result is arbitrary. ASE 2015 explicitly recommends against volumetric estimation from linear dimensions.
E-point septal separation (EPSS)
M-mode distance from the anterior mitral leaflet E-point to the interventricular septum in PLAX. EPSS > 7 mm suggests reduced EF; the correlation is strongest at the extremes.
Invalid when: aortic regurgitation (the AR jet holds the anterior leaflet away from the septum), mitral stenosis (restricted leaflet excursion), severe LVH or a small cavity, and marked septal hypertrophy. Useful as a rapid corroborative sign in a poor window, never as a stand-alone measure.
MAPSE and mitral annular sā²
MAPSE (mitral annular plane systolic excursion, M-mode at the lateral or septal annulus in A4C): normal ā„ 10ā12 mm; values < 8 mm indicate longitudinal dysfunction. Tissue Doppler sā² at the mitral annulus: normal ā„ 6ā7 cm/s (septal), lower values indicating longitudinal impairment.
Both are load-dependent, angle-dependent, and reflect basal segments only ā they miss apical disease entirely (which is precisely why they are normal in apical-ballooning stress cardiomyopathy while EF is markedly depressed).
Global longitudinal strain (GLS)
Speckle-tracking measurement of myocardial deformation. Reported as a negative number; more negative is better. Normal is approximately ā20% or more negative, with vendor-specific variability that makes cross-vendor comparison invalid.
GLS is the most sensitive routine measure of systolic function and detects abnormality when EF is normal. In septic shock it is abnormal in a large fraction of patients with preserved EF. Its relationship to outcome in sepsis is contested ā it identifies myocardial involvement reliably, but whether that involvement independently predicts mortality remains unresolved across cohorts.
ā ļø Evidence quality
GLS thresholds are derived from ambulatory populations and are vendor-dependent. In the ICU, GLS is load-dependent in the same direction as EF: it improves with vasodilatation and worsens with vasoconstriction. Serial GLS across a large change in noradrenaline dose is not comparing like with like.
dP/dt from the mitral regurgitant jet
When MR is present, the rate of pressure rise during isovolumic contraction is derived from the CW MR envelope, measuring the time interval between 1 m/s and 3 m/s:
dP/dt = 32 mmHg / Īt (s)(The 32 mmHg comes from 4(3²) ā 4(1²) = 36 ā 4.) Normal > 1200 mmHg/s; < 800 mmHg/s indicates significant systolic dysfunction. Less afterload-dependent than EF, which is its attraction in vasoplegia ā but it requires a measurable MR jet with a clean early envelope.
Diagnostic Synthesis
Parameter | Normal | Mildly abnormal | Moderately | Severely |
LVEF, men | 52ā72% | 41ā51% | 30ā40% | <30% |
LVEF, women | 54ā74% | 41ā53% | 30ā40% | <30% |
Fractional shortening | 25ā45% | ā | ā | ā |
MAPSE | ā„10 mm | ā | ā | <8 mm |
Septal sā² | ā„7 cm/s | ā | ā | <5 cm/s |
GLS (vendor-dependent) | ⤠ā20% | ā16 to ā20% | ā12 to ā16% | > ā12% |
EPSS | <7 mm | ā | ā | >13 mm |
dP/dt | >1200 mmHg/s | 1000ā1200 | 800ā1000 | <800 |
ICU-Specific Limitations
Confounder | Direction of error | Management |
Vasoplegia / low SVR | EF overestimates contractility | Report EF with the concurrent MAP and vasopressor dose; consider dP/dt or GLS |
High-dose vasoconstrictor | EF underestimates contractility | Same; re-assess after weaning |
Hypovolaemia | Small EDV, high EF, low SV | Always report SV or VTI alongside EF |
Tachycardia >120/min | Foreshortened filling, degraded tracing | State the heart rate; interpret cautiously |
Atrial fibrillation | Beat-to-beat variation | Average ā„5 beats or use index-beat method |
RV pressure overload | Septal flattening violates geometric assumptions | Use biplane Simpson's, not linear methods |
Post-cardiotomy | Paradoxical septal motion, normal for weeks | Judge by lateral/posterior wall and longitudinal indices |
Poor endocardial definition | Over-gain worsens it; borders drift outward | Use an ultrasound enhancing agent ā ASE-endorsed when ā„2 contiguous segments are non-diagnostic |
Therapeutic Logic
An EF value alone changes nothing. The action follows from the combination:
Pattern | Interpretation | Action |
Low EF + low VTI + dilated IVC + B-lines | Cardiogenic failure with congestion | Inotrope/afterload reduction; avoid fluid; consider MCS if lactate rising |
Low EF + low VTI + small LV + collapsing IVC | Hypovolaemia superimposed on chronic cardiomyopathy | Cautious small-volume challenge with reassessment of VTI |
High EF + low VTI + small LV | Underfilled/hyperdynamic | Volume, then vasopressor; exclude dynamic LVOT obstruction (Chapter 28) |
High EF + high VTI + low MAP | Vasoplegic high-output shock | Vasopressor; fluid will not fix the pressure deficit |
Normal EF + abnormal GLS/MAPSE | Early myocardial involvement | Prognostic flag; avoid escalating inotropes on this finding alone |
š Critical pitfall: Starting an inotrope on the basis of a low EF in a patient with a high stroke volume and a low SVR. The problem is arterial, not ventricular; inotropes worsen vasodilatation and arrhythmia. Always measure flow before treating a number.
š Critical pitfall: Reporting "normal LV systolic function" in a patient with a hyperdynamic, cavity-obliterating ventricle. This is not normal function ā it is a specific and actionable finding (hypovolaemia or vasoplegia, with a risk of dynamic LVOT obstruction).
- š” Clinical pearl: EF answers "how well does this ventricle empty at this afterload?" Stroke volume answers "how much blood is the patient receiving?" Only the second correlates with organ perfusion.
- š” Clinical pearl: Longitudinal indices fall first. A normal EF with MAPSE 6 mm and sā² 4 cm/s is an abnormal ventricle, and a normal-EF report is misleading.
- š” Clinical pearl: Record vasopressor dose and MAP in the report body, not the notes. It converts a snapshot into an interpretable data point for the next operator.
References
- Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults. J Am Soc Echocardiogr 2015;28:1ā39.
- Sanfilippo F, Huang S, Herpain A, et al. The PRICES statement. Intensive Care Med 2021;47:1ā13. PMID 33275163.
- Porter TR, Mulvagh SL, Abdelmoneim SS, et al. Clinical applications of ultrasonic enhancing agents in echocardiography: 2018 ASE guidelines update. J Am Soc Echocardiogr 2018;31:241ā74.
- Mitchell C, Rahko PS, Blauwet LA, et al. Guidelines for performing a comprehensive TTE examination in adults. J Am Soc Echocardiogr 2019;32:1ā64.